nivolumab,ipilimumab,cabozantinib
bms
['ipi/', '/ipi', 'cosmic313', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabo ', 'nivo']
#gu23 while pts w/ intermediate imdc risk group still show benefit from nivo/ipi/cabo we hope to understand the poorer outcomes in poor risk group through rna-seq #cosmic313 
Postdoctoral GU Oncology Research Fellow @DanaFarber | MD '2021, MSc '2019 @USJLiban 🏎️🎾📖